Retrospective 72 pediatric patients showing HCQ associated with a shorter duration of fever (
p=0.023), less progression (
p=0.016), and fewer return visits to the ER (
p=0.017).
López et al., 11/2/2020, retrospective, Spain, Europe, peer-reviewed, 7 authors.
risk of disease progression, 64.3% lower, RR 0.36, p = 0.02, treatment 5 of 36 (13.9%), control 14 of 36 (38.9%).
Effect extraction follows pre-specified rules prioritizing more serious
outcomes. For an individual study the most serious outcome may have a smaller
number of events and lower statistical signficance, however this provides the
strongest evidence for the most serious outcomes when combining the results of
many trials.